Potential Drug Target Or Biomarker: RBM41, A RNA-Binding Protein

Target Name: RBM41

NCBI ID: G55285

Potential Drug Target Or Biomarker: RBM41, A RNA-Binding Protein

RNA-binding protein 41 (RBM41) is a protein that is expressed in various tissues and cells of the human body. It plays a critical role in the regulation of gene expression and has been associated with various diseases, including cancer.

RBM41 is a 22-kDa protein that is expressed in the brain, heart, liver, and other tissues. It is composed of a 165 amino acid chain and has a calculated molecular mass of 19.9 kDa. RBM41 is predominantly expressed in the brain, with a relatively low expression level in the heart and other tissues.

The function of RBM41 is still not well understood, but it is known to play a role in the regulation of gene expression and cell signaling. RBM41 has been shown to interact with various proteins, including transcription factors, and has been shown to regulate the expression of target genes.

One of the most interesting aspects of RBM41 is its potential as a drug target or biomarker. RBM41 has been shown to play a role in the regulation of cancer cell growth and has been shown to be involved in the development of various types of cancer, including breast, ovarian, and prostate cancer.

In addition to its potential as a drug target, RBM41 has also been shown to be a potential biomarker for various types of cancer. RBM41 has been shown to be expressed in various types of cancer and has been shown to be involved in the regulation of cancer cell growth and progression.

Overall, RBM41 is a protein that is of great interest to researchers as a potential drug target or biomarker. Further research is needed to fully understand its function and its potential as a drug.

Protein Name: RNA Binding Motif Protein 41

Functions: May bind RNA

More Common Targets